Lidocaine plasters for postherpetic neuralgia?

Drug and Therapeutics Bulletin

Volumn 46, Issue 2, 2008, Pages 14-16

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; CAPSAICIN; GABAPENTIN; LIDOCAINE; NARCOTIC ANALGESIC AGENT; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VERSATIS;

ANALGESIC ACTIVITY; ARTICLE; BLOOD PLACENTA BARRIER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DERMATITIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG METABOLISM; DRUG RESPONSE; DRUG TOLERABILITY; ERYTHEMA; HERPES ZOSTER; HUMAN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; RECOMMENDED DRUG DOSE; SKIN ANAPHYLAXIS; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN PRURITUS; TREATMENT DURATION; UNITED KINGDOM; VESICULAR RASH; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; BANDAGES; HUMANS; LIDOCAINE; NEURALGIA, POSTHERPETIC;

EID: 39449115438     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2008.01.0002     Document Type: Article

References (12)

1. Hall GC et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006; 122: 156-62.
2. Drug treatment of neuropathic pain. DTB 2000; 38: 89-93.
3. Versatis 5% medicated plaster. Summary of product characteristics, UK. Grunenthal Ltd, January 2007.
4. Khaliq W et al. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD004846. DOI: 10.1002/14651858.CD004846.pub2. [Date of most recent substantive amendment 13 February 2007].
5. Rowbotham MC et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65: 39-44.
6. Galer BS et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80: 533-8.
7. Alper BS, Lewis PR. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract 2002; 51: 121-8.
8. Food and Drug Administration, 2005. Lidoderm (lidocaine) patch [online]. Available: http://www.fda.gov/cder/foi/nda/99/20612.htm [Accessed 21 January 2008].
9. Dubinsky RM et al. Practice parameter: treatment of postherpetic neuralgia. Am Acad Neurol 2004; 63: 959-65.
10. Hempenstall K et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: 628-44.
11. Rowbotham MC et al. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37: 246-53.
12. Scottish Medicines Consortium, 2007. Lidocaine 5% plaster (Versatis). No (334/06) Grunethal GmbH [online]. NHS Scotland. Available: http://www.scottishmedicines.org.uk/smc/files/ lidocaine%205%20percent%20plaster%20_Versatis%20(334-06).pdf [Accessed 21 January 2008].